In the case of semaglutide, the immune systems response might mistakenly target the medication, leading to skin inflammation
Article by: Whittany Gibson, RDN Whittany is the Co-Founder of Alterra Health and a seasoned Registered Dietitian specializing in bariatric and medical weight loss
Medicare GLP-1 Bridge Program: What Medicare Beneficiaries Need to Know Medicare GLP-1 Bridge Program: Weight Loss Medication Coverage in 2026 Beginning July 1, 2026 , the Centers for Medicare & Medicaid Services will launch a new temporary program called the Medicare GLP-1 Bridge Program
Once activated, the GLP-1 receptor sends signals to appetite centers in the hypothalamus
Our research is still ongoing, and WVU Medicine is helping lead the way
Consultations are all handled via secure asynchronous messaging or video calls